Document is current
Any future updates will be listed below
-
Authors
Abdalla, Tasnim https://orcid.org/0000-0001-7033-4725
Lowes, Michelle A. https://orcid.org/0000-0003-4256-478X
Kaur, Nirmal https://orcid.org/0000-0002-8243-2071
Micheletti, Robert G. https://orcid.org/0000-0003-2517-7008
Steinhart, A. Hillary https://orcid.org/0000-0001-7794-6150
Alavi, Afsaneh https://orcid.org/0000-0003-1171-4917
- License Information
-
More Information
Article History
First Online: 5 January 2021
Declarations
:
: The authors received no financial support for the research, authorship, and/or publication of this article.
: Afsaneh Alavi has acted as a consultant, advisor, and/or received research funding from Abbvie, Galderma, Janssen, LEO Pharma, Novartis, Sanofi Aventis, Valeant, Boehringer-Ingelheim, DSBiopharma, Eli Lilly, Glenmark, Incyte, Ilkos, Merck Serono, Pfizer, Regeneron, Roche, Xenon, and Xoma. Michelle A. Lowes has served on the advisory boards for Abbvie, Janssen, and Viela Bio, and consulted for Almirall, BSN, Incyte, Janssen, Kymera, and Xbiotech. Tasnim Abdalla, Robert G. Micheletti, and Nirmal Kaur have no conflicts of interest that are directly relevant to the content of this article. A. Hillary Steinhart has acted as a consultant, advisor and/or received research funding from Abbvie, Janssen, Merck, Pfizer, Roche, Arena Pharmaceuticals, Celgene, Takeda, RedHill Biopharma, and Nubiyota.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design. Afsaneh Alavi conceived the idea for the article. Tasnim Abdalla performed the literature search and data analysis. The first draft of the manuscript was written by Tasnim Abdalla and all authors contributed to writing, reviewing, and critically revising previous versions of the manuscript. All authors read and approved the final manuscript.
